Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Anti-CLEC4A Antibody
  • Anti-CLEC4A Antibody
Antibodies.com

Anti-CLEC4A Antibody

Price on request

SKUPriceQuantity
A37323-50

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Manufactured by Antibodies.com, this rabbit polyclonal reagent is raised against CLEC4A (C-type lectin domain family 4 member A) and is intended for researchers studying innate immune lectin receptors and dendritic-cell biology. The immunogen is a recombinant human CLEC4A protein, and the antibody is affinity-purified using that immunogen to maximise specificity. It is supplied at a working concentration of 1.0 mg/mL in a 50 µL vial, formulated in phosphate-buffered saline (without Mg²⁺ and Ca²⁺) at pH 7.4, containing 150 mM NaCl, 0.02% sodium azide as a preservative, and 50% glycerol for stability. The host species is Rabbit, the clonality is Polyclonal, and the antibody is provided in an Unconjugated format, making it suitable for secondary-labelling workflows of the researcher's choice. Application validation covers Western Blotting (WB), and according to the supplier's product page the reagent is reactive with Human and Mouse samples. The product is shipped at 4 °C on blue ice; on receipt it should be aliquoted and stored at –20 °C, with repeated freeze/thaw cycles avoided to preserve activity. The Antibodies.com datasheet specifically states that the reagent detects the endogenous level of total CLEC4A protein, supporting its use in expression-profiling studies. For research use only; not intended for diagnostic or therapeutic applications. Dispatched from the Antibodies.com distribution centre in St. Louis, MO, with a typical lead time of 6–9 business days, this polyclonal anti-CLEC4A antibody offers a reliable tool for laboratories characterising CLEC4A expression across immune-cell populations.